About BioIVT
BioIVT is a company based in Westbury (United States) founded in 2015 was acquired by Linden Capital Partners in October 2021. BioIVT has completed 19 acquisitions, including Ascendance Biotechnology, Asterand Bioscience and Biological Specialty. BioIVT operates in a competitive market with competitors including Bio Rad, Abcam, Siemens Healthineers, Merck and Quanterix, among others.
- Headquarter Westbury, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$22.57 K (USD), Grant
Jan 01, 2021
-
Investors
European Union
& 3 more
-
Employee Count
Not available
-
Investments & Acquisitions
Ascendance Biotechnology
& 18 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of BioIVT
Unlock access to complete
Software Development Team
27 people
Sales and Marketing
14 people
Leadership Team
12 people
Operations Team
11 people
Senior Team
9 people
Product Management Team
6 people
Human Resources and Administration
5 people
Finance and Accounting
5 people
Unlock access to complete
Funding Insights of BioIVT
Investors in BioIVT
BioIVT has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Linden Capital Partners and Lineage Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Lineage Capital is engaged in private equity partnerships.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Private equity investments are focused on the healthcare sector.
|
Locked | Locked | Locked |
Investor details for BioIVT
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioIVT
BioIVT has strategically engaged in corporate development activities, having acquired 19 companies. Notable acquisitions include Ascendance Biotechnology, Asterand Bioscience and Biological Specialty.
Investment portfolio details for BioIVT
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Micro-liver cell-based platforms for use in safety testing, and pharmaceutical, biotherapeutic, and diagnostic product development.
|
Locked | Locked | 2015 | Locked | |
|
Biotech models for drug safety and interaction predictions are provided.
|
Locked | Locked | 2012 | Locked | |
|
Novel drug assays from explant-derived human primary cells are developed.
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for BioIVT
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - BioIVT
Detailed financials for BioIVT
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioivt Comparisons
Peer comparison for BioIVT
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioIVT
BioIVT operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Abcam, Siemens Healthineers, Merck and Quanterix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Portfolio of products and services for life science research and clinical diagnostic markets
|
|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
AI-based medical diagnostics are developed for healthcare applications.
|
|
| Locked | Locked | Locked |
Merck is engaged in science and technology solutions globally.
|
|
| Locked | Locked | Locked |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
Detailed competitors of BioIVT
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioivt
Complete news archive for BioIVT
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioIVT
BioIVT was founded in 2015.
BioIVT is headquartered in Westbury, United States. It is registered at Westbury, New York, United States.
Provider of in vitro diagnostic products and assay services. The company specializes in control and disease state matrices manufactured from human and animal blood, plasma, serum, tissues, and other fluids which are used in drug discovery, compound development, clinical and research diagnostics. They also provide hepatocyte and microsome products used in the preclinical industry. It provides in-vitro research services such as transporters assay, cell biology, gene expression, and drug-drug interaction assay.
BioIVT's top competitors include Abcam, Biocare Medical and Sino Biological.
BioIVT has made 19 acquisitions, including Ascendance Biotechnology, Asterand Bioscience, and Biological Specialty.
BioIVT has 4 investors. Key investors include European Union, Linden Capital Partners, Lineage Capital, and National Science Foundation.